亚太地区外周栓塞线圈市场预测（2031年）-区域分析-按类型、材料和应用

2023 年亚太週边栓塞线圈市值为 1.3845 亿美元，预计到 2031 年将达到 2.0452 亿美元；预计 2023 年至 2031 年的复合年增长率为 5.0%。

栓塞线圈应用范围不断扩大，推动亚太外周栓塞线圈市场发展

週边栓塞线圈市场的公司持续专注于新产品的发布和市场审批，这有助于他们提升销售额。以下列举了外周栓塞线圈市场的一些值得关注的发展。 2024年1月，国家药品监督管理局批准了由Zylox-Tonbridge医疗技术有限公司生产的ZYLOX Phoenix外周可分离纤维弹簧圈栓塞系统。週边血管介入是此栓塞线圈系统最常见的应用。内臟动脉瘤的栓塞治疗、腹主动脉瘤的内漏管理、咯血和动静脉瘘是该系统的其他重要临床应用，其安全性和有效性得到了国际认可。 2022年4月，波士顿科学公司（Boston Scientific Corporation）的EMBOLD纤维可分离弹簧圈（Fibered Detachable Coil）获得美国食品药物管理局（FDA）的510(k)上市许可。本产品旨在阻断或降低週边血管的血流速度。波士顿科学公司介入肿瘤学产品组合的最新成员旨在用于各种栓塞手术，这些手术必然是微创治疗，旨在阻断一条或多条血管以阻塞或减少血流。 EMBOLD纤维可分离弹簧圈采用由三个弹簧圈组成的单一平台，方便医师根据不同患者的需求和解剖结构进行治疗。因此，预计新产品的开发和市场批准将为预测期内週边栓塞弹簧圈市场的成长创造机会。

亚太地区外周栓塞线圈市场概况

亚太地区外周栓塞线圈市场细分为中国、印度、日本、韩国、澳洲和亚太其他地区。该地区市场的成长归因于医疗基础设施的不断发展，以及欧洲各国腹主动脉瘤、急性胃肠道出血 (AGIB) 和肿瘤的发生率较高。根据 2022 年 4 月发表在《BMC Public Health》上的一篇文章，中国主动脉瘤的疾病负担从 1990 年到 2020 年急剧增加，男性、老年人口和西部省份居民的死亡率更高。静脉曲张是一种常见疾病，影响 30% 的印度人口，尤其是女性。病情会随着时间的推移而发展，导致出血、凝血和溃疡等併发症，影响患者的生活品质。静脉曲张患者极易发生深部静脉血栓形成，因为静脉淤滞和损伤常导致浅静脉炎，浅静脉炎可经由穿孔动脉扩散并进入深部静脉系统。

日本国立癌症中心数据显示，2022年日本新增肿瘤病例超过100万，肿瘤相关死亡病例超过38万400例。大肠直肠癌、胃癌、肺癌和摄护腺癌是日本最常见的癌症，占所有癌症病例的45%以上。日本前列腺癌的诊断数量在过去十年中增加了1.8倍。大量人被诊断出患有由各种可能的风险因素（最明显的是人口老化）引起的癌症，前列腺癌病例正在快速增长。上消化道出血（AGIB）是一种常见的急症，发病率和死亡率都很高。它分为上消化道出血（UGIB）和下消化道出血（LGIB），两者决定了患者的评估和治疗方案。根据昆士兰州政府统计，在澳大利亚，UGIB每年影响每10万人中50-150人，死亡率为6-8%。同一来源也指出，目前尚无澳洲LGIB病例的资料。根据美国国立卫生研究院（NIH）发表的一篇文章，2023年，创伤性损伤在韩国主要死因中排名第三，占总死亡率的9.2%。创伤在年轻人中更为常见，男性报告的病例数是女性的两倍。韩国可预防的院内创伤死亡率高于其他已开发国家，介于5%至10%之间。

亚太地区週边栓塞线圈市场收入及预测（2031 年）（百万美元）

亚太外周栓塞线圈市场细分

亚太地区外周栓塞线圈市场按类型、材料、应用和国家分类。

根据类型，亚太地区週边栓塞线圈市场分为可分离线圈和可推动线圈。 2023年，可分离线圈占据了较大的市占率。

就材质而言，亚太地区週边栓塞线圈市场主要分为铂金、铂金水凝胶以及铂钨合金。铂金在2023年占据了最大的市场份额。

根据应用，亚太地区週边栓塞线圈市场细分为出血和创伤、畸形、肿瘤、内臟动脉瘤、II型内漏和静脉曲张。出血和创伤领域在2023年占据了最大的市场。

根据国家/地区，亚太地区週边栓塞线圈市场细分为中国、日本、印度、澳洲、韩国和亚太其他地区。 2023年，中国占据了亚太地区週边栓塞线圈市场份额的主导地位。

Medtronic Plc；Penumbra, Inc.；Balt；Boston Scientific Corp；Cook Medical Holdings LLC；Wallaby Medical；Spartan Micro Inc.；ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO.; LTD.；Terumo Corp；以及 NeuroSafe Medical Co. Ltd. 是亚太地区外周栓塞线圈市场领先的公司。

目录

第一章：简介

第二章：执行摘要

• 关键见解
• 市场吸引力

第三章：研究方法

• 二次研究
• 初步研究
  • 假设表述：
  • 宏观经济因素分析：
  • 显影基数：
  • 数据三角测量：
  • 国家级资料：

第四章：亚太週边栓塞线圈市场－关键市场动态

• 市场驱动因素
  • 主动脉瘤盛行率上升
  • 癌症发生率上升
• 市场限制
  • 栓塞期间或之后出现的併发症
• 市场机会
  • 栓塞线圈应用范围的扩大
• 未来趋势
  • 封装密度的重要性日益凸显
• 驱动因素和限制因素的影响：

第五章：週边栓塞线圈市场－亚太地区分析

• 亚太地区外周栓塞线圈市场概况
• 外周栓塞线圈市场收入（2021-2031）
• 週边栓塞线圈市场预测分析
• 週边栓塞线圈市场：公司定位

第六章：亚太地区週边栓塞线圈市场分析－依产品类型

• 概述
• 可拆卸弹簧圈
• 可推式线圈

第七章：亚太地区週边栓塞线圈市场分析-依材料

• 概述
• 铂
• 铂金和水凝胶
• 铂钨合金

第八章：亚太地区週边栓塞线圈市场分析-依应用

• 概述
• 出血与创伤
• 畸形
• 肿瘤
• 内臟动脉瘤
• II型内漏
• 静脉曲张

第九章：亚太週边栓塞线圈市场－国家分析

• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太其他地区

第 10 章：週边栓塞线圈市场-产业格局

• 概述
• 週边栓塞线圈市场的成长策略
• 无机成长策略
  • 概述
• 有机成长策略
  • 概述

第 11 章：公司简介

• Medtronic Plc
• Penumbra, Inc.
• Balt
• Boston Scientific Corp
• Cook Medical Holdings LLC
• Wallaby Medical
• Spartan Micro Inc.
• ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
• Terumo Corp
• NeuroSafe Medical Co. Ltd

第 12 章：附录

The Asia Pacific peripheral embolization coils market was valued at US$ 138.45 million in 2023 and is expected to reach US$ 204.52 million by 2031; it is estimated to register a CAGR of 5.0% from 2023 to 2031.

Expanding Range of Applications of Embolization Coils Boosts Asia Pacific Peripheral Embolization Coils Market

Companies operating in the peripheral embolization coils market constantly focus on new product launches and marketing approval, which helps them improve their sales. A few of the noteworthy developments in the peripheral embolization coils market are mentioned below. In January 2024, the National Medical Products Administration provided marketing approval for the ZYLOX Phoenix Peripheral Detachable Fibered Coil Embolization System manufactured by Zylox-Tonbridge Medical Technology Co Ltd. Peripheral vascular intervention is the most prevalent application of this embolization coil system. Embolization treatment of visceral aneurysms, endoleak management of abdominal aortic aneurysms, hemoptysis, and arteriovenous fistula are the other important clinical applications of the system, which are internationally recognized for their safety and efficacy. In April 2022, Boston Scientific Corporation received 510(k) clearance from the US Food and Drug Administration (FDA) for the EMBOLD Fibered Detachable Coil designed to block or reduce the blood flow rate in the peripheral vasculature. The newest addition to Boston Scientific's interventional oncology portfolio was designed for use in various embolization procedures, necessarily minimally invasive treatments intended to block one or more blood vessels to obstruct or reduce blood flow. The EMBOLD Fibered Detachable Coil features a single platform consisting of three coils, making it simpler for physicians to address various patient needs and anatomies. Thus, new product developments and marketing approvals are anticipated to create opportunities for growth of the peripheral embolization coils market during the forecast period.

Asia Pacific Peripheral Embolization Coils Market Overview

The Asia Pacific peripheral embolization coil market is segmented into China, India, Japan, South Korea, Australia, and Rest of Asia Pacific. Market growth in this region is ascribed to the continuously advancing healthcare infrastructure, and the significant incidence of abdominal aortic aneurysms, acute gastrointestinal bleeding (AGIB), and tumors in different European countries. According to an article published in BMC Public Health in April 2022, the disease burden of aortic aneurysms in China increased dramatically from 1990 to 2020, with greater mortality rates among men, elderly populations, and residents of western provinces. Varicose veins, a common condition, affect 30% of the Indian population, particularly women. Conditions can develop over time, resulting in complications such as bleeding, clotting, and ulceration that impact the quality of life of patients. Patients with varicose veins are highly susceptible to developing deep vein thrombosis because venous stasis and damage often result in superficial phlebitis, which can spread through perforating arteries and enter the deep venous system.

According to the National Cancer Centre of Japan, the country recorded more than 1million new tumor cases and 380,400 tumor-related deaths in 2022. Colorectal, stomach, lung, and prostate tumors are the most frequent cancers in Japan, accounting for over ~45% of all cancer cases. Prostate cancer diagnoses in Japan have increased 1.8 times in the last decade. A vast number of people are being diagnosed with cancer caused by a variety of possible risk factors, most notably population aging, and the cases of prostate cancer are surging at a rapid pace. AGIB is a common emergency condition with high morbidity and death rates. It is divided into upper gastrointestinal bleeding (UGIB) and lower gastrointestinal bleeding (LGIB), which determine the course of patient evaluation and treatment. According to the Queensland Government, in Australia, UGIB affects 50-150 individuals per 100,000 people per year, with a 6-8% fatality rate. The same source also states that there is no data is available on LGIB cases in Australia. According to an article published by NIH, in 2023, traumatic injuries ranked third among the leading causes of death in South Korea, accounting for 9.2% of the total mortality. Trauma is more common in younger people, and the cases reported in men are twice those in women. South Korea has a higher preventable in-hospital trauma fatality rate than other developed countries, which ranges from 5% to 10%.

Asia Pacific Peripheral Embolization Coils Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Peripheral Embolization Coils Market Segmentation

The Asia Pacific peripheral embolization coils market is categorized into type, material, application, and country.

Based on type, the Asia Pacific peripheral embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2023.

In terms of material, the Asia Pacific peripheral embolization coils market is categorized into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2023.

By application, the Asia Pacific peripheral embolization coils market is segmented into bleedings & trauma, malformations, tumours, visceral aneurysm, endoleak type II, and varicose veins. The bleedings & trauma segment held the largest market share in 2023.

Based on country, the Asia Pacific peripheral embolization coils market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific peripheral embolization coils market share in 2023.

Medtronic Plc; Penumbra, Inc.; Balt; Boston Scientific Corp; Cook Medical Holdings LLC; Wallaby Medical; Spartan Micro Inc.; ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO.; LTD.; Terumo Corp; and NeuroSafe Medical Co. Ltd. are among the leading companies operating in the Asia Pacific peripheral embolization coils market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights
• 2.2 Market Attractiveness

3. Research Methodology

• 3.1 Secondary Research
• 3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Peripheral Embolization Coils Market - Key Market Dynamics

• 4.1 Market Drivers
  • 4.1.1 Rise in Prevalence of Aortic Aneurysm
  • 4.1.2 Increase in Incidence of Cancer
• 4.2 Market Restraints
  • 4.2.1 Complications Arising During or After Embolization
• 4.3 Market Opportunities
  • 4.3.1 Expanding Range of Applications of Embolization Coils
• 4.4 Future Trends
  • 4.4.1 Growing Importance of Packing Density
• 4.5 Impact of Drivers and Restraints:

5. Peripheral Embolization Coils Market - Asia Pacific Analysis

• 5.1 Asia Pacific Peripheral Embolization Coils Market Overview
• 5.2 Peripheral Embolization Coils Market Revenue (US$ Million), 2021-2031
• 5.3 Peripheral Embolization Coils Market Forecast Analysis
• 5.4 Peripheral Embolization Coils Market: Company Positioning

6. Asia Pacific Peripheral Embolization Coils Market Analysis - by Product Type

• 6.1 Overview
• 6.2 Detachable Coil
  • 6.2.1 Overview
  • 6.2.2 Detachable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• 6.3 Pushable Coil
  • 6.3.1 Overview
  • 6.3.2 Pushable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

7. Asia Pacific Peripheral Embolization Coils Market Analysis - by Material

• 7.1 Overview
• 7.2 Platinum
  • 7.2.1 Overview
  • 7.2.2 Platinum: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• 7.3 Platinum & Hydrogel
  • 7.3.1 Overview
  • 7.3.2 Platinum & Hydrogel: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• 7.4 Platinum Tungsten Alloy
  • 7.4.1 Overview
  • 7.4.2 Platinum Tungsten Alloy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Peripheral Embolization Coils Market Analysis - by Application

• 8.1 Overview
• 8.2 Bleedings & Trauma
  • 8.2.1 Overview
  • 8.2.2 Bleedings & Trauma: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• 8.3 Malformations
  • 8.3.1 Overview
  • 8.3.2 Malformations: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• 8.4 Tumors
  • 8.4.1 Overview
  • 8.4.2 Tumors: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• 8.5 Visceral Aneurysms
  • 8.5.1 Overview
  • 8.5.2 Visceral Aneurysms: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• 8.6 Endoleak Type II
  • 8.6.1 Overview
  • 8.6.2 Endoleak Type II: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• 8.7 Varicose Veins
  • 8.7.1 Overview
  • 8.7.2 Varicose Veins: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Peripheral Embolization Coils Market - Country Analysis

• 9.1 Asia Pacific: Market Overview
  • 9.1.1 Asia Pacific: Peripheral Embolization Coils Market Breakdown, by Key Country, 2023 and 2031 (%)
    • 9.1.1.1 China: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.1.1.1.1 China: Peripheral Embolization Coils Market Breakdown, by Product Type
      • 9.1.1.1.2 China: Peripheral Embolization Coils Market Breakdown, by Material
      • 9.1.1.1.3 China: Peripheral Embolization Coils Market Breakdown, by Application
    • 9.1.1.2 Japan: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.1.1.2.1 Japan: Peripheral Embolization Coils Market Breakdown, by Product Type
      • 9.1.1.2.2 Japan: Peripheral Embolization Coils Market Breakdown, by Material
      • 9.1.1.2.3 Japan: Peripheral Embolization Coils Market Breakdown, by Application
    • 9.1.1.3 India: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.1.1.3.1 India: Peripheral Embolization Coils Market Breakdown, by Product Type
      • 9.1.1.3.2 India: Peripheral Embolization Coils Market Breakdown, by Material
      • 9.1.1.3.3 India: Peripheral Embolization Coils Market Breakdown, by Application
    • 9.1.1.4 Australia: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.1.1.4.1 Australia: Peripheral Embolization Coils Market Breakdown, by Product Type
      • 9.1.1.4.2 Australia: Peripheral Embolization Coils Market Breakdown, by Material
      • 9.1.1.4.3 Australia: Peripheral Embolization Coils Market Breakdown, by Application
    • 9.1.1.5 South Korea: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.1.1.5.1 South Korea: Peripheral Embolization Coils Market Breakdown, by Product Type
      • 9.1.1.5.2 South Korea: Peripheral Embolization Coils Market Breakdown, by Material
      • 9.1.1.5.3 South Korea: Peripheral Embolization Coils Market Breakdown, by Application
    • 9.1.1.6 Rest of Asia Pacific: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.1.1.6.1 Rest of Asia Pacific: Peripheral Embolization Coils Market Breakdown, by Product Type
      • 9.1.1.6.2 Rest of Asia Pacific: Peripheral Embolization Coils Market Breakdown, by Material
      • 9.1.1.6.3 Rest of Asia Pacific: Peripheral Embolization Coils Market Breakdown, by Application

10. Peripheral Embolization Coils Market-Industry Landscape

• 10.1 Overview
• 10.2 Growth Strategies in the Peripheral Embolization Coils Market
• 10.3 Inorganic Growth Strategies
  • 10.3.1 Overview
• 10.4 Organic Growth Strategies
  • 10.4.1 Overview

11. Company Profiles

• 11.1 Medtronic Plc
  • 11.1.1 Key Facts
  • 11.1.2 Business Description
  • 11.1.3 Products and Services
  • 11.1.4 Financial Overview
  • 11.1.5 SWOT Analysis
  • 11.1.6 Key Developments
• 11.2 Penumbra, Inc.
  • 11.2.1 Key Facts
  • 11.2.2 Business Description
  • 11.2.3 Products and Services
  • 11.2.4 Financial Overview
  • 11.2.5 SWOT Analysis
  • 11.2.6 Key Developments
• 11.3 Balt
  • 11.3.1 Key Facts
  • 11.3.2 Business Description
  • 11.3.3 Products and Services
  • 11.3.4 Financial Overview
  • 11.3.5 SWOT Analysis
  • 11.3.6 Key Developments
• 11.4 Boston Scientific Corp
  • 11.4.1 Key Facts
  • 11.4.2 Business Description
  • 11.4.3 Products and Services
  • 11.4.4 Financial Overview
  • 11.4.5 SWOT Analysis
  • 11.4.6 Key Developments
• 11.5 Cook Medical Holdings LLC
  • 11.5.1 Key Facts
  • 11.5.2 Business Description
  • 11.5.3 Products and Services
  • 11.5.4 Financial Overview
  • 11.5.5 SWOT Analysis
  • 11.5.6 Key Developments
• 11.6 Wallaby Medical
  • 11.6.1 Key Facts
  • 11.6.2 Business Description
  • 11.6.3 Products and Services
  • 11.6.4 Financial Overview
  • 11.6.5 SWOT Analysis
  • 11.6.6 Key Developments
• 11.7 Spartan Micro Inc.
  • 11.7.1 Key Facts
  • 11.7.2 Business Description
  • 11.7.3 Products and Services
  • 11.7.4 Financial Overview
  • 11.7.5 SWOT Analysis
  • 11.7.6 Key Developments
• 11.8 ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
  • 11.8.1 Key Facts
  • 11.8.2 Business Description
  • 11.8.3 Products and Services
  • 11.8.4 Financial Overview
  • 11.8.5 SWOT Analysis
  • 11.8.6 Key Developments
• 11.9 Terumo Corp
  • 11.9.1 Key Facts
  • 11.9.2 Business Description
  • 11.9.3 Products and Services
  • 11.9.4 Financial Overview
  • 11.9.5 SWOT Analysis
  • 11.9.6 Key Developments
• 11.10 NeuroSafe Medical Co. Ltd
  • 11.10.1 Key Facts
  • 11.10.2 Business Description
  • 11.10.3 Products and Services
  • 11.10.4 Financial Overview
  • 11.10.5 SWOT Analysis
  • 11.10.6 Key Developments

12. Appendix

• 12.1 About The Insight Partners
• 12.2 Glossary of Terms

List Of Tables

• Table 1. Asia Pacific Peripheral Embolization Coils Market Segmentation
• Table 2. Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• Table 3. China: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
• Table 4. China: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
• Table 5. China: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
• Table 6. Japan: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
• Table 7. Japan: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
• Table 8. Japan: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
• Table 9. India: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
• Table 10. India: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
• Table 11. India: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
• Table 12. Australia: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
• Table 13. Australia: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
• Table 14. Australia: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
• Table 15. South Korea: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
• Table 16. South Korea: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
• Table 17. South Korea: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
• Table 18. Rest of Asia Pacific: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
• Table 19. Rest of Asia Pacific: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
• Table 20. Rest of Asia Pacific: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
• Table 21. Recent Inorganic Growth Strategies in the Peripheral Embolization Coils Market
• Table 22. Recent Organic Growth Strategies in the Peripheral Embolization Coils Market
• Table 23. Glossary of Terms, Peripheral Embolization Coils Market

List Of Figures

• Figure 1. Asia Pacific Peripheral Embolization Coils Market Segmentation, by Country
• Figure 2. Peripheral Embolization Coils Market - Key Market Dynamics
• Figure 3. Impact Analysis of Drivers and Restraints
• Figure 4. Peripheral Embolization Coils Market Revenue (US$ Million), 2021-2031
• Figure 5. Company Positioning
• Figure 6. Peripheral Embolization Coils Market Share (%) - by Product Type (2023 and 2031)
• Figure 7. Detachable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 8. Pushable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 9. Peripheral Embolization Coils Market Share (%) - by Material (2023 and 2031)
• Figure 10. Platinum: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 11. Platinum & Hydrogel: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 12. Platinum Tungsten Alloy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 13. Peripheral Embolization Coils Market Share (%) - by Application (2023 and 2031)
• Figure 14. Bleedings & Trauma: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 15. Malformations: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 16. Tumors: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 17. Visceral Aneurysms: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 18. Endoleak Type II: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 19. Varicose Veins: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 20. Asia Pacific: Peripheral Embolization Coils Market, by Key Country - Revenue (2023) (US$ Million)
• Figure 21. Asia Pacific: Peripheral Embolization Coils Market Breakdown, by Key Countries, 2023 and 2031 (%)
• Figure 22. China: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 23. Japan: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 24. India: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 25. Australia: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 26. South Korea: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 27. Rest of Asia Pacific: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
• Figure 28. Growth Strategies in the Peripheral Embolization Coils Market